Cargando…
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009041/ https://www.ncbi.nlm.nih.gov/pubmed/33824042 http://dx.doi.org/10.1016/j.vaccine.2021.03.086 |
| _version_ | 1783672804726538240 |
|---|---|
| author | Azzi, Lorenzo Focosi, Daniele Dentali, Francesco Baj, Andreina Maggi, Fabrizio |
| author_facet | Azzi, Lorenzo Focosi, Daniele Dentali, Francesco Baj, Andreina Maggi, Fabrizio |
| author_sort | Azzi, Lorenzo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8009041 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80090412021-03-31 Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients Azzi, Lorenzo Focosi, Daniele Dentali, Francesco Baj, Andreina Maggi, Fabrizio Vaccine Commentary Elsevier Ltd. 2021-04-28 2021-03-30 /pmc/articles/PMC8009041/ /pubmed/33824042 http://dx.doi.org/10.1016/j.vaccine.2021.03.086 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Azzi, Lorenzo Focosi, Daniele Dentali, Francesco Baj, Andreina Maggi, Fabrizio Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients |
| title | Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients |
| title_full | Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients |
| title_fullStr | Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients |
| title_full_unstemmed | Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients |
| title_short | Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients |
| title_sort | anti-sars-cov-2 rbd igg responses in convalescent versus naïve bnt162b2 vaccine recipients |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009041/ https://www.ncbi.nlm.nih.gov/pubmed/33824042 http://dx.doi.org/10.1016/j.vaccine.2021.03.086 |
| work_keys_str_mv | AT azzilorenzo antisarscov2rbdiggresponsesinconvalescentversusnaivebnt162b2vaccinerecipients AT focosidaniele antisarscov2rbdiggresponsesinconvalescentversusnaivebnt162b2vaccinerecipients AT dentalifrancesco antisarscov2rbdiggresponsesinconvalescentversusnaivebnt162b2vaccinerecipients AT bajandreina antisarscov2rbdiggresponsesinconvalescentversusnaivebnt162b2vaccinerecipients AT maggifabrizio antisarscov2rbdiggresponsesinconvalescentversusnaivebnt162b2vaccinerecipients |